Regulation of gene expression in vivo following transduction by two separate rAAV vectors

Nature Biotechnology

Volumn 16, Issue 8, 1998, Pages 757-761

  Rendahl, Katherine G ^a   Leff, Stuart E ^a   Otten, Gillis R ^a   Spratt, S Kaye ^b   Bohl, Delphine ^b   Van Roey, Melinda ^a   Donahue, Brian A ^a   Cohen, Lawrence K ^b   Mandel, Ronald J ^a   Danos, Olivier ^b   Snyder, Richard O ^a  

^a CELL GENESYS INC   (United States)

^b INSTITUT PASTEUR   (France)

Author keywords

Erythropoietin tetracycline; Gene therapy

Indexed keywords

ERYTHROPOIETIN; TETRACYCLINE DERIVATIVE; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; DATA ANALYSIS; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; IMMUNE RESPONSE; OPERATOR GENE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

3T3 CELLS; ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; DEPENDOVIRUS; ERYTHROPOIETIN; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOCRIT; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; MUSCLE, SKELETAL; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES, CYTOTOXIC; TETRACYCLINE; TRANS-ACTIVATORS; TRANSGENES;

ADENO-ASSOCIATED VIRUS; EUKARYOTA; MURINAE;

EID: 0031879481     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt0898-757     Document Type: Article

References (31)

1. Naffakh, N. and Danos, O. 1996. Gene transfer for erythropoiesis enhancement. Mol. Med. Today 2:343-348.
2. Gossen, M. and Bujard, H. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
3. No, D., Yao, T.R, and Evans, R.M. 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93:3346-3351.
4. Rivera, V.M., Clackson, T., Nateson, S., Pollock, R., Amara, J.F., Keenan, T. et al. 1996. A humanized system for pharmacological control of gene expression. Nat. Med. 2:1028-1032.
5. Wang, Y., DeMayo, F.J., Tsai, S.Y., and O'Malley, B.W. 1997. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nat. Biotech. 15:239-243.
6. Rinsch, C., Regulier, E., Deglon, N., Dalle, B., Beuzard, Y., and Aebischer, P. 1997. A gene therapy approach to regulated delivery of erythropoietin as a function of oxygen tension. Hum. Gene Ther. 8:1881-1889.
7. Furth, P.A., St. Onge, L. Boger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., and Hennighausen, L. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promotor. Proc. Natl. Acad. Sci. USA 91:9302-9306.
8. Kessler, P.D., Podsakoff, G.M., Chen, X., McQuiston, S.A., Colosi, P.C., Matelis, L.A. et al. 1996. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93:14082-14087.
9. Xiao, X., Li, J., and Samulski, R. J. 1996. Efficient long-term gene transfer into muscle of immunocompetent mice by an adeno-associated virus vector. J. Virol. 70:8098-8108.
10. Fisher, K.J., Jooss, K., Alston, J., Yang, Y., Haecker, S.E., High, K. et al. 1997. Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3:306-312.
11. Murphy, J.E., Zhou, S., Giese, K., Williams, L.T., Escobedo, J.A., and Dwarki, V.J. 1997. Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin. Proc. Natl. Acad. Sci. USA 94:13921-13926.
12. Snyder, R.O., Spratt, S.K., Lagarde, C., Bohl, D., Kaspar, B.K., Sloan, B.S. et al. 1997. Efficient and stable AAV-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8:1891-1900.
13. Clark, K.R., Sferra, T.J., and Johnson, P.R. 1997. Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther. 8:659-669.
14. Dai, Y., Schwarz, E.M., Gu, D., Zhang, W.-W., Sarvetnick, N., and Verma, I. 1995. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
15. Herzog, R.W., Hagstron, J.N., Kung, S.-H., Tai, S.J., Wilson, J.M., Fisher, K. J., and High, K.A. 1997. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94:5804-5809.
16. Hall, Z. and Ralston, E. 1989. Nuclear domains in muscle cells. Cell 59:771-772.
17. Snyder, R.O., Miao, C.H., Patijn, G.A., Spratt, S.K., Danos, O., Gown, A.M. et al. 1997. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16:270-276.
18. Flannery, J.G., Zolotukhin, S., Vaquero, M.I., LaVail, M.M., Muzyczka, N., and Hauswirth, W.W. 1997. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA 94:6916-6921.
19. Dhawan, J., Rando, T.A., Elson, S.L., Bujard, H., and Blau, H.M. 1995. Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat. Cell. Mol. Genet. 21:233-240.
20. Bohl, D., Naffakh, N., and Heard, J.M. 1997. Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts. Nat. Med. 3:299-305.
21. Kistner, A., Gossen, M., Zimmermann, F., Jerecic, J., Ullmer, C., Lubbert, H., and Bujard, H. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93:10933-10938.
22. McLaughlin, S. K., Collis, P., Hermonat, P. L., and Muzyczka, N. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1963-1973.
23. Miao, C.H., Snyder, R.O., Schowalter, D.B., Patijn, G.A., Donahue, B.A., Winther, B., and Kay, M.A. 1998. The Kinetics of rAAV Integration in the Liver. Nat Genet. 19:13-15.
24. Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L., Dwarki, V.J. et al. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
25. Manning, W.C., Paliard, X., Zhou, S., Bland, M.P., Lee, A.Y., Hong, K. et al. 1997. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J. Virol. 71:7960-7962.
26. Mandel, R.J., Rendahl, K.G., Spratt, S.K., Snyder, R.O., Cohen, L.K., and Leff, S.E. 1998. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-Cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18:4271-4264.
27. Goodman, S., Xiao, X., Donahue, R., Moulton, A., Miller, J., Walsh, C., Young, M.S., Samulski, R.J., and Nienhuis, A.W. 1994. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84:1492-1500.
28. McCown, T.J., Xiao, X., Li, J., Breese, G.R., and Samulski, R.J. 1996. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713:99-107.
29. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M.L. 1997. Construction of Adenovirus Vectors through Cre-lox Recombination. J. Virol. 71:1842-1849.
30. Neering, S.J., Hardy, S.F., Minamoto, D., Spratt, S. Kaye, and Jordan, C.T. 1996. Transduction of Primitive Human Hematopoietic Cells with Recombinant Adenovirus Vectors. Blood 88:1147-1155.
31. Kirk, R.E. 1968. Experimental design: procedures for the behavioral sciences. Brooks/Cole, Belmont, CA.